These results were consistent with the study on DSS-induced colitis mouse model, which showed oral administration of daidzein ameliorated the ulcerative colitis and suppressed the expression of TNF-α, interleukin-1β (IL-1β), and IL-622. This evidence concerns the gene IL1B and ulcerative colitis.